This year SHL is going to speak about the requirements on prefillable containers for the perfect fit into devices. The issue is important and widely discussed in the pharmaceutical and manufacturing industries and SHL is proud to make its contribution to the debate.
In addition to being a speaker at the seminar, SHL will also participate in the exhibition accompanying it. The spotlight will be on our two latest products – Molly® 2.25 and Molly® C.
Molly® 2.25 is our large-volume auto injector based on the Molly® preconfigured program. Mike Weng, Executive Director of Business Development for Asia comments: “We are very proud to bring Molly 2.25 to Japan. As our first large-volume auto injector,
Molly® 2.25 creates the long-needed bridge between larger volume primary containers and drug delivery.”
SHL’s most recent and most innovative product – Molly® C – is a connected auto injector that transmits injection data to the user’s mobile device. It was developed as a part of our connectivity-dedicated program Alubena® to showcase the benefits and prospects of connected products.
Molly® 2.25, Molly® C and other SHL products will be available for demonstration at the exhibition. The exhibition will take place parallel to the seminar in the East Room of Sola City Conference Center on the 2nd floor.